Showing results (381-390 of 470) with videos related to
Sort By:
Pageof 47
The Lancet. Gastroenterology & Hepatology|September 10, 2021
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelinesGlenn K Bonney, Claire Alexandra Chew, Peter Lodge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal CancerAndreas Seeber, Francesca Battaglin, Kai Zimmer, et al.Breast Cancer Research and Treatment|April 22, 2017
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathwayTanda M Dudenkov, James N Ingle, Aman U Buzdar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitorsJames N Ingle, Daniel J Schaid, Paul E Goss, et al.BMC Cancer|October 8, 2014
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerJordan M Reese, Vera J Suman, Malayannan Subramaniam, et al.Clinical Breast Cancer|November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic ExperienceNusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.NPJ Breast Cancer|December 19, 2023
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancerSwaathi Jayaraman, Xinyan Wu, Krishna R Kalari, et al.Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.JAMA|October 8, 2009
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifenWerner Schroth, Matthew P Goetz, Ute Hamann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)Judy C Boughey, Vera J Suman, Jia Yu, et al.Pageof 47